[ad_1] BRUSEL, 20. listopadu 2025 /PRNewswire/ — V rámci Světového týdne povědomí o antimikrobiální rezistenci (AMR) ukazuje zpráva Světové zdravotnické organizace o globálním sledování antibiotické rezistence z roku 2025, že každá šestá bakteriální infekce na […]
Tag: Viatris Inc.
Viatris Reports Third Quarter 2025 Results and Updates 2025 Financial Guidance
[ad_1] Delivers Total Revenues in Line With Expectations, Reflecting Strong Execution of its Global Business Makes Late-Stage Pipeline Progress Including NDA Submission for Low-Dose Estrogen Weekly Patch Acquires Aculys Pharma Including Rights to Pitolisant in […]
Viatris Announces Early Tender Results and Increase of Pending Maximum Tender Offer
[ad_1] PITTSBURGH, Sept. 17, 2024 /PRNewswire/ — Viatris Inc. (NASDAQ: VTRS, “Viatris” or the “Company”) announced today the early tender results of the previously announced cash tender offer (the “Maximum Tender Offer”) of its subsidiary […]
Viatris Announces Expiration and Results of Any and All Cash Tender Offers
[ad_1] PITTSBURGH, Sept. 10, 2024 /PRNewswire/ — Viatris Inc. (NASDAQ: VTRS, “Viatris” or the “Company”) announced today that the previously announced cash tender offers (the “Any and All Tender Offers” and each, an “Any and […]
Viatris Announces Cash Tender Offers for Certain Outstanding Notes
[ad_1] PITTSBURGH, Sept. 4, 2024 /PRNewswire/ — Viatris Inc. (NASDAQ: VTRS, “Viatris” or the “Company”) announced today that it and its subsidiaries, Mylan Inc. (“Mylan”) and Utah Acquisition Sub Inc. (“Utah Acquisition” and, together with […]














